REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • December 21st, 2022 • Black Bird Biotech, Inc. • Miscellaneous manufacturing industries
This REGISTRATION RIGHTS AGREEMENT (this "Agreement"), dated as of December 13, 2022, is entered into by and between BLACK BIRD BIOTECH, INC., a Nevada corporation (the "Company"), and MAST HILL FUND, L.P., a Delaware limited partnership (together with it permitted assigns, the “Investor”). Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in the equity purchase agreement by and between the parties hereto, dated as of the date hereof (as amended, restated, supplemented or otherwise modified from time to time, the "Purchase Agreement").
COMMON STOCK PURCHASE WARRANT BLACK BIRD BIOTECH, INC.Security Agreement • December 21st, 2022 • Black Bird Biotech, Inc. • Miscellaneous manufacturing industries • Nevada
This COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received (in connection with the execution of the Purchase Agreement (as defined below)), Mast Hill Fund, L.P., a Delaware limited partnership (including any permitted and registered assigns, the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date of issuance hereof, to purchase from Black Bird Biotech, Inc., a Nevada corporation (the “Company”), 170,000,000 shares of Common Stock (the “Warrant Shares”) (whereby such number may be adjusted from time to time pursuant to the terms and conditions of this Warrant) at the Exercise Price per share then in effect. This Warrant is issued by the Company as of the date hereof in connection with that certain equity purchase agreement dated December 13, 2022, by and among the Company and the Holder (the “Purchase Agreement”).
EQUITY PURCHASE AGREEMENTEquity Purchase Agreement • December 21st, 2022 • Black Bird Biotech, Inc. • Miscellaneous manufacturing industries • Nevada
This equity purchase agreement is entered into as of December 13, 2022 (this “Agreement”), by and between Black Bird Biotech, Inc., a Nevada corporation (the “Company”), and Mast Hill Fund, L.P., a Delaware limited partnership (the “Investor”).
